Adams J S, Ren S Y, Arbelle J E, Horiuchi N, Gray R W, Clemens T L, Shany S
Division of Endocrinology and Metabolism, Cedars-Sinai Medical Center, University of California School of Medicine, Los Angeles 90048.
Endocrinology. 1994 Jun;134(6):2567-73. doi: 10.1210/endo.134.6.8194484.
To better understand the extrarenal production of active vitamin D metabolites by cells of the monocyte/macrophage lineage, we investigated the 25-hydroxyvitamin D (25OHD)-1-hydroxylation reaction in the v-myc-transformed chick myelomonocytic cell line HD-11; the 1-hydroxylation reaction in this cell line has a high affinity for 25-hydroxylated vitamin D substrates, is localized to mitochondria, and is associated with cytochrome P450 activity. In this study we demonstrated that the HD-11 cell 1-hydroxylation reaction in vitro is not affected by the majority of extracellular regulatory factors that modulate expression of the renal 25OHD-1-hydroxylase in vivo. A 50% increase in extracellular calcium and phosphate concentrations, physiological inhibitory events for renal 1,25-dihydroxyvitamin D [1,25-(OH)2D] synthesis, did not decrease basal expression of the HD-11 cell 1-hydroxylation reaction, nor did a 50% decrease in extracellular calcium and phosphate concentrations, stimulatory signals for the 1-hydroxylase in vivo, increase 1,25-(OH)2D3 synthesis in vitro. Receptor-saturating concentrations of PTH and PTH-related peptide were similarly without effect. In contrast, the HD-11 1-hydroxylation reaction was significantly stimulated in a dose-dependent fashion by the macrophage stimulatory agents lipopolysaccharide [P < 0.001 at a maximum effective concentration (EC100) of 25 micrograms/ml] and interferon-gamma (P < 0.001 at EC100 of 1000 IU/ml) and by insulin-like growth factor-I (P < 0.01 at EC100 of 15 nM) with the rank order of stimulation being interferon-gamma > lipopolysaccharide > insulin-like growth factor-I. Dexamethasone (> or = 10 nM) and the cytochrome P450 inhibitors (EC100, 20 microM), ketoconazole, clotrimazole, and menadione, all significantly inhibited the HD-11 cell 1-hydroxylation reaction. The naphthoquinone menadione, which blocks electron transfer to the P450-associated enzyme, was the most effective inhibitor of the reaction in both intact cells (3 +/- 1% of basal expression; P < or = 0.002) and after reconstitution of HD-11 cell mitochondrial extracts with a ferredoxin, reductase, O2, and NADPH (5 +/- 1% of basal; P < or = 0.02). We have also shown that 1,25-(OH)2D3 produced from substrate 25OHD3 appears to exert an endogenous (intracrine) inhibitory effect on HD-11 cell growth; incubation of HD-11 cells with a concentration of ketoconazole (10 microM) known to reduce 1,25-(OH)2D3 production by roughly 50% restored 50% of the growth deficit induced by 1,25-(OH)2D3 (EC100, 100 nM).(ABSTRACT TRUNCATED AT 400 WORDS)
为了更好地理解单核细胞/巨噬细胞系细胞产生活性维生素D代谢产物的肾外机制,我们研究了v-myc转化的鸡骨髓单核细胞系HD-11中的25-羟基维生素D(25OHD)-1-羟化反应;该细胞系中的1-羟化反应对25-羟化维生素D底物具有高亲和力,定位于线粒体,且与细胞色素P450活性相关。在本研究中,我们证明,体外HD-11细胞的1-羟化反应不受体内调节肾25OHD-1-羟化酶表达的大多数细胞外调节因子的影响。细胞外钙和磷浓度增加50%,这是肾1,25-二羟基维生素D[1,25-(OH)2D]合成的生理抑制事件,并未降低HD-11细胞1-羟化反应的基础表达;细胞外钙和磷浓度降低50%,这是体内1-羟化酶的刺激信号,也未增加体外1,25-(OH)2D3的合成。受体饱和浓度的甲状旁腺激素(PTH)和PTH相关肽同样无作用。相比之下,巨噬细胞刺激剂脂多糖[最大有效浓度(EC100)为25微克/毫升时P<0.001]、干扰素-γ(EC100为1000国际单位/毫升时P<0.001)和胰岛素样生长因子-I(EC100为15纳摩尔时P<0.01)以剂量依赖方式显著刺激HD-11的1-羟化反应,刺激强度顺序为干扰素-γ>脂多糖>胰岛素样生长因子-I。地塞米松(≥10纳摩尔)和细胞色素P450抑制剂(EC100,20微摩尔)酮康唑、克霉唑和甲萘醌均显著抑制HD-11细胞的1-羟化反应。萘醌甲萘醌可阻断电子传递给与P450相关的酶,在完整细胞中(基础表达的3±1%;P≤0.002)以及用铁氧化还原蛋白、还原酶、O2和NADPH重构HD-11细胞线粒体提取物后(基础的5±1%;P≤0.02)都是该反应最有效的抑制剂。我们还表明,由底物25OHD3产生的1,25-(OH)2D3似乎对HD-11细胞生长发挥内源性(自分泌)抑制作用;用已知可使1,25-(OH)2D3产生减少约50%的酮康唑浓度(10微摩尔)孵育HD-11细胞,可恢复1,25-(OH)2D3(EC100,100纳摩尔)诱导的生长缺陷的50%。(摘要截断于400字)